home / stock / aplif / aplif quote
Last: | $0.0255 |
---|---|
Change Percent: | 11.66% |
Open: | $0.02734 |
Close: | $0.0255 |
High: | $0.029 |
Low: | $0.0255 |
Volume: | 1,400 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.0255 | $0.02734 | $0.0255 | $0.029 | $0.0255 | 1,400 | 07-05-2024 |
$0.031 | $0.0285 | $0.03095 | $0.031 | $0.0285 | 1,219 | 07-04-2024 |
$0.03095 | $0.0285 | $0.03095 | $0.03095 | $0.0285 | 1,219 | 07-03-2024 |
$0.0295 | $0 | $0.0295 | $0 | $0 | 4,268 | 07-02-2024 |
$0.0295 | $0 | $0.0295 | $0 | $0 | 4,268 | 06-28-2024 |
$0.0295 | $0.0316 | $0.0295 | $0.0316 | $0.0295 | 6,068 | 06-27-2024 |
$0.02585 | $0.0255 | $0.02585 | $0.0262 | $0.0255 | 56,000 | 06-26-2024 |
$0.0256 | $0.03089 | $0.0256 | $0.03089 | $0.0256 | 51,000 | 06-25-2024 |
$0.0256 | $0.0256 | $0.0256 | $0.0256 | $0.0256 | 56,000 | 06-24-2024 |
$0.0295 | $0.0295 | $0.0295 | $0.0295 | $0.0295 | 20,597 | 06-21-2024 |
$0.03076 | $0 | $0.03076 | $0 | $0 | 5 | 06-20-2024 |
$0.03076 | $0.03076 | $0.03076 | $0.03076 | $0.03076 | 3,000 | 06-14-2024 |
$0.03076 | $0.03076 | $0.03076 | $0.03076 | $0.03076 | 7,000 | 06-13-2024 |
$0.03085 | $0.03085 | $0.03085 | $0.03085 | $0.03085 | 1,000 | 06-11-2024 |
$0.03115 | $0.0332 | $0.03115 | $0.0332 | $0.03115 | 2,100 | 06-10-2024 |
$0.03065 | $0.0289 | $0.03065 | $0.03065 | $0.0289 | 110,043 | 06-07-2024 |
$0.03125 | $0.02908 | $0.03125 | $0.0372 | $0.02908 | 221,100 | 06-05-2024 |
$0.02706 | $0.02706 | $0.02706 | $0.02706 | $0.02706 | 24,055 | 06-03-2024 |
$0.0256 | $0.0256 | $0.0256 | $0.0256 | $0.0256 | 32,000 | 05-31-2024 |
$0.02745 | $0.0295 | $0.02745 | $0.0295 | $0.02745 | 7,000 | 05-30-2024 |
News, Short Squeeze, Breakout and More Instantly...
Appili Therapeutics Inc Company Name:
APLIF Stock Symbol:
OTCMKTS Market:
Appili Therapeutics Inc Website:
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES HALIFAX, Nova Scotia, July 02, 2024 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “ Company ” or “ Appili ”), a biopharmace...
LIKMEZ™ (ATI-1501) for Metronidazole Oral Suspension 500mg/5mL launched and commercial sales ongoing Funding commitments from U.S. Air Force Academy intended to advance ATI-1701 toward an IND submission to the FDA Engaging regulatory authorities to align on ATI-1801 ...
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES HALIFAX, Nova Scotia, April 26, 2024 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “ Company ” or “ Appili ”), a biopharmac...